BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24761846)

  • 1. Ginsenoside Rg1 induces apoptosis through inhibition of the EpoR-mediated JAK2/STAT5 signalling pathway in the TF-1/ Epo human leukemia cell line.
    Li J; Wei Q; Zuo GW; Xia J; You ZM; Li CL; Chen DL
    Asian Pac J Cancer Prev; 2014; 15(6):2453-9. PubMed ID: 24761846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total saponins of Panax ginseng (TSPG) promote erythroid differentiation of human CD34+ cells via EpoR-mediated JAK2/STAT5 signaling pathway.
    Chen D; Zuo G; Li C; Hu X; Guan T; Jiang R; Li J; Lin X; Li F; Luo C; Wang H; Lei C; Long X; Wang Y; Wang J
    J Ethnopharmacol; 2009 Nov; 126(2):215-20. PubMed ID: 19735711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine/paracrine erythropoietin signalling promotes JAK/STAT-dependent proliferation of human cervical cancer cells.
    Lopez TV; Lappin TR; Maxwell P; Shi Z; Lopez-Marure R; Aguilar C; Rocha-Zavaleta L
    Int J Cancer; 2011 Dec; 129(11):2566-76. PubMed ID: 21442620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK2/STAT5/Bcl-xL signalling is essential for erythropoietin-mediated protection against apoptosis induced in PC12 cells by the amyloid β-peptide Aβ25-35.
    Ma R; Hu J; Huang C; Wang M; Xiang J; Li G
    Br J Pharmacol; 2014 Jul; 171(13):3234-45. PubMed ID: 24597613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis.
    Ueda F; Tago K; Tamura H; Funakoshi-Tago M
    J Biol Chem; 2017 Feb; 292(5):1826-1846. PubMed ID: 27998978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
    Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
    Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin ameliorates early brain injury after subarachnoid haemorrhage by modulating microglia polarization via the EPOR/JAK2-STAT3 pathway.
    Wei S; Luo C; Yu S; Gao J; Liu C; Wei Z; Zhang Z; Wei L; Yi B
    Exp Cell Res; 2017 Dec; 361(2):342-352. PubMed ID: 29102603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells.
    Tong H; Ren Y; Zhang F; Jin J
    Eur J Haematol; 2008 Oct; 81(4):259-66. PubMed ID: 18616510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lovastatin suppresses erythropoietin receptor surface expression through dual inhibition of glycosylation and geranylgeranylation.
    Hamadmad SN; Hohl RJ
    Biochem Pharmacol; 2007 Aug; 74(4):590-600. PubMed ID: 17586475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT5 as a Key Protein of Erythropoietin Signalization.
    Tóthová Z; Tomc J; Debeljak N; Solár P
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT5 activation is critical for the transformation mediated by myeloproliferative disorder-associated JAK2 V617F mutant.
    Funakoshi-Tago M; Tago K; Abe M; Sonoda Y; Kasahara T
    J Biol Chem; 2010 Feb; 285(8):5296-307. PubMed ID: 20028972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of supplemental erythropoietin on its receptor expression and signal transduction pathways in rat model of retinal detachment.
    Xie Z; Chen F; Wu X; Zhuang C; Zhu J; Wang J; Ji H; Wang Y; Hua X
    Curr Eye Res; 2012 Feb; 37(2):138-44. PubMed ID: 22251399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
    Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
    Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
    Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
    Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total saponins of Panax ginseng induces K562 cell differentiation by promoting internalization of the erythropoietin receptor.
    Zuo G; Guan T; Chen D; Li C; Jiang R; Luo C; Hu X; Wang Y; Wang J
    Am J Chin Med; 2009; 37(4):747-57. PubMed ID: 19655412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylated CIS suppresses the Epo or JAK2 V617F mutant-triggered cell proliferation through binding to EpoR.
    Funakoshi-Tago M; Moriwaki T; Ueda F; Tamura H; Kasahara T; Tago K
    Cell Signal; 2017 Feb; 31():41-57. PubMed ID: 28038963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells.
    Feldman L; Wang Y; Rhim JS; Bhattacharya N; Loda M; Sytkowski AJ
    Prostate; 2006 Feb; 66(2):135-45. PubMed ID: 16161153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells.
    Ammarguellat F; Llovera M; Kelly PA; Goffin V
    Biochem Biophys Res Commun; 2001 Jun; 284(4):1031-8. PubMed ID: 11409898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
    Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
    EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epo-induced erythroid maturation is dependent on Plcγ1 signaling.
    Schnöder TM; Arreba-Tutusaus P; Griehl I; Bullinger L; Buschbeck M; Lane SW; Döhner K; Plass C; Lipka DB; Heidel FH; Fischer T
    Cell Death Differ; 2015 Jun; 22(6):974-85. PubMed ID: 25394487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.